Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from TG Therapeutics

TG Therapeutics Clears Technical Benchmark, Hitting 90-Plus RS Rating

TG Therapeutics sees its Relative Strength Rating hit the elite 90-plus level.

Investors Business Daily

TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?

TG Therapeutics shares soared Wednesday after sales of its multiple sclerosis treatment met expectations. TGTX stock topped its 200-day line.

Investors Business Daily

TG Therapeutics Reverses Its 225% Winning Streak On Lackluster Guidance

Sales of a new multiple sclerosis drug from TG crushed analysts' expectations, but TGTX stock tumbled on lackluster 2024 guidance.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating

TG Therapeutics sees its Relative Strength Rating move into the elite 90-plus level.

Investors Business Daily

Sales Of TG Therapeutics' New Product Doubled — Here's Why Shares Halved

Sales of TG Therapeutics' highly anticipated multiple sclerosis drug, Briumvi, missed forecasts on Tuesday and TGTX stock plummeted.

Investors Business Daily

How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg

Roche unveiled positive results Thursday for a rival to TG Therapeutics' infusion for multiple sclerosis patients, and TGTX stock crashed.

Investors Business Daily

Dow Jones Futures Fall: Tesla Runs On GM Charging Deal; Boeing, Apple Chipmaker In Buy Areas

The market rally showed constructive action Thursday. Boeing and Apple chipmaker Taiwan Semiconductor are in buy areas. Red-hot Tesla ran late on a GM charging deal.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets

TG Therapeutics more than doubled Wall Street's first-quarter sales expectations on Monday, and TGTX stock rocketed to a five-month high.

Investors Business Daily

Top-Notch Biotech TG Therapeutics Breaks Out On 'Solid Jump' In Sales

TG Therapeutics' new MS drug, Briumvi, experienced a "solid jump" in March sales, according to a report. TGTX stock broke out Tuesday.

Investors Business Daily

1 2

People

Michael Weiss

15 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.